DC-661

N/A

Report date: 2025/06/11 10:34:07

NME

Base Information

Drug NameDC-661

Drug Alias Namedimeric chloroquine (Pinpoint Therapeutics/University of Pennsylvania)mTORC1 inhibitors (University of Pennsylvania/MD Anderson Cancer Center/Wistar Institute of Anatomy & Biology)DQ-660DC-661DQ-661

ClassificationSmall molecules

Mechanisms of ActionPalmitoyl-protein thioesterase 1 inhibitorsRadiosensitizers

TargetsPalmitoyl-protein thioesterase 1

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pancreatic NeoplasmsColonic Neoplasms +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPinpoint Therapeutics LLC

China Registration ClassN/A

Develop Information

Active CompaniesPinpoint Therapeutics LLC

Inactive CompaniesUniversity Of Pennsylvania

Active IndicationsCoronavirus Disease 2019 (COVID-19)Pancreatic NeoplasmsColonic Neoplasms +[4]

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A